PCI BIOTECH AS

0379 OSLO

Finances

Share Ownership

Return on Equity

−102,15 %

Current Ratio

5,18

Debt-to-Equity Ratio

0,01

Key figures (NOK)	2022	2021	2020	2019
Revenue	4 750 000	6 273 000	7 368 000	9 392 000
Net Income	−51 594 000	−82 293 000	−78 668 000	−88 925 000
Total Assets	62 830 000	109 469 000	140 562 000	159 169 000
Total Equity	50 506 000	73 393 000	102 748 000	105 077 000

Income (NOK)	2022	2021	2020	2019
Revenue	4 750 000	6 273 000	7 368 000	9 392 000
Expenditure	55 975 000	87 333 000	84 825 000	93 614 000
Operating Profit	−51 225 000	−81 060 000	−77 457 000	−84 222 000
Financial Income	1 700 000	750 000	2 302 000	2 721 000
Financial Costs	2 069 000	1 983 000	3 513 000	7 424 000
Financial Balance	−369 000	−1 233 000	−1 211 000	−4 703 000
Earnings Before Tax	−51 594 000	−82 293 000	−78 668 000	−88 925 000
Tax	0	0	0	0
Net Income	−51 594 000	−82 293 000	−78 668 000	−88 925 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	723 000	7 660 000	7 993 000	6 283 000
Total Current Assets	62 107 000	101 809 000	132 569 000	152 886 000
Total Assets	62 830 000	109 469 000	140 562 000	159 169 000
Total Retained Equity	0	0	0	0
Total Equity	50 506 000	73 393 000	102 748 000	105 077 000
Total Long-Term Debt	327 000	1 277 000	32 000	2 576 000
Total Current Debt	11 998 000	34 799 000	37 783 000	51 516 000
Total Equity and Debt	62 831 000	109 469 000	140 563 000	159 169 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	0	0	0	0
Other Income	4 750 000	6 273 000	7 368 000	9 392 000
Revenue	4 750 000	6 273 000	7 368 000	9 392 000
Cost of Goods Sold	0	0	0	0
Salary Costs	0	0	0	0
Depreciation	0	0	0	0
Impairment	0	0	0	0
Expenditure	55 975 000	87 333 000	84 825 000	93 614 000
Operating Profit	−51 225 000	−81 060 000	−77 457 000	−84 222 000
Financial Income	1 700 000	750 000	2 302 000	2 721 000
Financial Costs	2 069 000	1 983 000	3 513 000	7 424 000
Financial Balance	−369 000	−1 233 000	−1 211 000	−4 703 000
Dividends	0	0	0	0
Net Income	−51 594 000	−82 293 000	−78 668 000	−88 925 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	723 000	7 660 000	7 993 000	6 283 000
Total Tangible Assets	723 000	7 660 000	7 993 000	6 283 000
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	723 000	7 660 000	7 993 000	6 283 000
Stock	0	0	0	0
Total Investments	0	0	0	0
Cash, Bank	55 968 000	89 642 000	119 493 000	138 308 000
Total Current Assets	62 107 000	101 809 000	132 569 000	152 886 000
Total Assets	62 830 000	109 469 000	140 562 000	159 169 000
Total Equity	50 506 000	73 393 000	102 748 000	105 077 000
Short-Term Group Debt	0	0	19 021 000	28 011 000
Total Long-Term Debt	327 000	1 277 000	32 000	2 576 000
Creditors	0	0	5 130 000	8 452 000
Unpaid Taxes	0	0	1 978 000	4 565 000
Dividends	0	0	0	0
Other Current Debt	11 998 000	34 799 000	11 654 000	10 488 000
Total Current Debt	11 998 000	34 799 000	37 783 000	51 516 000
Total Equity and Debt	62 831 000	109 469 000	140 563 000	159 169 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−102,15 %	−112,13 %	−76,56 %	−84,63 %
Debt-to-Equity Ratio	0,01	0,02	0	0,02
Operating Profit Margin	−1 078,42 %	−1 292,2 %	−1 051,26 %	−896,74 %
Current Ratio	5,18	2,93	3,51	2,97
Quick Ratio	5,18	2,93	3,51	2,97
Equity Ratio	0,8	0,67	0,73	0,66
Gross Profit Margin	100 %	100 %	100 %	100 %